In the first half of the current fiscal year, imports of surgical products and equipment reached $621.59 million, an increase from the $557.68 million recorded in the same period last fiscal year. Imports increased by 13.03 percent in terms of...
The increase in chronic illnesses is anticipated to drive the need for specialty generic products. There is expected to be a significant increase in the size of the specialty generics market in the coming years. The amount is projected to reach...
India's medical technology sector is projected to reach exports worth USD 20 billion by 2030. The industry body CII mentioned that in order to boost international shipments, the sector requires more government incentives and improved ease of doing...
The pharmaceutical sector is projected to reach $70.3 billion, with a 9 percent growth expected from FY25 to FY27, fueled by rising exports to nations such as the US, as well as by new products introduced by Indian pharmaceutical firms. It is...
In the upcoming five years, almost 70 percent of international pharmaceutical companies are predicted to experience yearly growth of over 10 percent in India. International pharmaceutical corporations have been essential in the change by bringing...
Dr Reddy's Laboratories announced the introduction of Toripalimab in India for treating recurrent or metastatic nasopharyngeal carcinoma. Nasopharyngeal carcinoma (NPC) is an uncommon, fast-growing type of head and neck cancer that starts in the...
India's pharmaceutical industry, known for being a major player in global healthcare, is projected to reach an impressive value of USD 450 billion by 2047. India continues to be a major player in the international pharmaceutical market, with...
The increasing preference for biologics and biosimilars is fueling the demand for the sterile injectable contract manufacturing sector. The market size for sterile injectable contract manufacturing was worth USD 15.96 billion in 2024 and is...
The growth of the global manufacturing execution system in life sciences market is due to the rising need for real-time data and analytics and increasing regulatory compliance. The pharmaceutical sector is quickly embracing digital technology...
Many pharmaceutical companies prioritize digital transformation to enhance their ability to collect, analyze, and store data for future use, driving the increasing demand for the pharma 4.0 market. Utilizing industry 4.0 technology in the...
, CDSCO.jpg)
